News
EU approves Norvatis’ Cosentyx for childhood arthritis
Novartis has announced the European Commission has approved Cosentyx, to be used alone or in combination with methotrexate.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Novartis has announced the European Commission has approved Cosentyx, to be used alone or in combination with methotrexate.